Article

Prognostic Implications of Codon-Specific<i>KRAS</i>Mutations in Localized and Advanced Stages of Pancreatic Cancer

2025-02-05

Abstract excerpt

<h4>Introduction</h4> While KRAS mutations represent the primary oncogenic driver in pancreatic ductal adenocarcinoma (PDAC), the association between codon-specific alterations and patient outcomes remains poorly elucidated, largely due to a lack of datasets coupling genomic profiling with rich clinical annotations across disease stages. <h4>Patients and Methods</h4> We utilized AACR’s GENIE Biopharma Consortium P...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3732d899-7900-5910-b4f8-ba200986185c
DOI: 10.1101/2025.02.03.25321601

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prognostic Implications of Codon-Specific<i>KRAS</i>Mutations in Localized and Advanced Stages of Pancreatic CancerDOI 10.1101/2025.02.03.25321601Read

Prognostic Implications of Codon-Specific KRAS Mutations in Localized and Advanced Stages of Pancreatic Cancer.Semantic proximity Read

Prognostic Properties of KRAS Gene Mutation Subtypes in Resected Pancreatic Ductal Adenocarcinoma.Semantic proximity Read

Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma.Semantic proximity Read

Prognostic value of KRAS gene mutations in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis.Semantic proximity Read

The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal AdenocarcinomaSemantic proximity Read

Impact of KRAS Mutations and Co-mutations on Clinical Outcome in Pancreatic Ductal AdenocarcinomaSemantic proximity Read

Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer.Semantic proximity Read

The KRAS mutational spectrum and its clinical implications in pancreatic cancer.Semantic proximity Read

Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease.Semantic proximity Read

Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected Pancreatic Ductal Adenocarcinoma Reveals KRAS G12D and Mutant TP53 Combination as an Independent Predictor of Clinical Outcome.Semantic proximity Read

Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinomaSemantic proximity Read

Prognostic and therapeutic impact of the KRAS G12C mutation in colorectal cancerSemantic proximity Read